{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:52:18Z","timestamp":1777870338870,"version":"3.51.4"},"reference-count":9,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-024-02078-4","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T14:45:30Z","timestamp":1730990730000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Oxalate nephropathy from high-dose intravenous vitamin C in a patient with multiple myeloma"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8436-544X","authenticated-orcid":false,"given":"Guangchen","family":"Zou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avi Z.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,11,7]]},"reference":[{"key":"2078_CR1","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00240-016-0868-7","volume":"44","author":"J Knight","year":"2016","unstructured":"Knight J, Madduma-Liyanage K, Mobley JA, Assimos DG, Holmes RP (2016) Ascorbic acid intake and oxalate synthesis. Urolithiasis 44:289\u2013297","journal-title":"Urolithiasis"},{"key":"2078_CR2","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1001\/archinte.1985.00360050220044","volume":"145","author":"JM Lawton","year":"1985","unstructured":"Lawton JM, Conway LT, Crosson JT, Smith CL, Abraham PA (1985) Acute oxalate nephropathy after massive ascorbic acid administration. Arch Intern Med 145:950\u2013951","journal-title":"Arch Intern Med"},{"key":"2078_CR3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1056\/NEJM198501173120301","volume":"312","author":"CG Moertel","year":"1985","unstructured":"Moertel CG, Fleming TR, Creagan ET, Rubin J, O\u2019Connell MJ, Ames MM (1985) High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. N Engl J Med 312:137\u2013141","journal-title":"N Engl J Med"},{"key":"2078_CR4","doi-asserted-by":"publisher","first-page":"4232","DOI":"10.1158\/1078-0432.CCR-22-0655","volume":"28","author":"F Wang","year":"2022","unstructured":"Wang F, He M-M, Xiao J, Zhang Y-Q, Yuan X-L, Fang W-J et al (2022) A randomized, open-label, multicenter, phase 3 study of high-dose vitamin C plus FOLFOX \u00b1 bevacizumab versus FOLFOX \u00b1 bevacizumab in unresectable untreated metastatic colorectal cancer (VITALITY study). Clin Cancer Res Off J Am Assoc Cancer Res 28:4232\u20134239","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"2078_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011414","volume":"5","author":"SJ Padayatty","year":"2010","unstructured":"Padayatty SJ, Sun AY, Chen Q, Espey MG, Drisko J, Levine M (2010) Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects. PLoS ONE 5:e11414","journal-title":"PLoS ONE"},{"key":"2078_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s13730-018-0366-6","volume":"8","author":"WV Lin","year":"2018","unstructured":"Lin WV, Turin CG, McCormick DW, Haas C, Constantine G (2018) Ascorbic acid-induced oxalate nephropathy: a case report and discussion of pathologic mechanisms. CEN Case Rep 8:67\u201370","journal-title":"CEN Case Rep"},{"key":"2078_CR7","doi-asserted-by":"publisher","first-page":"e620","DOI":"10.1097\/CCM.0000000000004396","volume":"48","author":"F Yanase","year":"2020","unstructured":"Yanase F, Fujii T, Naorungroj T, Belletti A, Luethi N, Carr AC et al (2020) Harm of IV high-dose vitamin C therapy in adult patients: a scoping review. Crit Care Med 48:e620\u2013e628","journal-title":"Crit Care Med"},{"key":"2078_CR8","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1345\/aph.1E634","volume":"39","author":"J Bromley","year":"2005","unstructured":"Bromley J, Hughes BGM, Leong DCS, Buckley NA (2005) Life-threatening interaction between complementary medicines: cyanide toxicity following ingestion of amygdalin and vitamin C. Ann Pharmacother 39:1566\u20131569","journal-title":"Ann Pharmacother"},{"key":"2078_CR9","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1038\/leu.2009.83","volume":"23","author":"G Perrone","year":"2009","unstructured":"Perrone G, Hideshima T, Ikeda H, Okawa Y, Calabrese E, Gorgun G et al (2009) Ascorbic acid inhibits antitumor activity of bortezomib in vivo. Leukemia 23:1679\u20131686","journal-title":"Leukemia"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-02078-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-024-02078-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-02078-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:54:06Z","timestamp":1777564446000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/38\/2\/751\/8307182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,7]]},"references-count":9,"alternative-id":["2078"],"URL":"https:\/\/doi.org\/10.1007\/s40620-024-02078-4","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,7]]},"assertion":[{"value":"21 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors have declared no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This case report is exempt from IRB approval at our institution.\u00a0This case report\u00a0was conducted in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments as well as our\u00a0institutional guidelines for human subject research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent has been obtained from the patient on publishing the case report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}